Dr. Roger Pertwee stands as a pioneering figure in the field of cannabinoid pharmacology whose groundbreaking research has fundamentally shaped our understanding of the endocannabinoid system. Currently serving as Emeritus Professor at the University of Aberdeen's School of Medical Sciences, he brings decades of expertise to his ongoing scientific investigations despite his formal retirement. His academic journey began at the University of Oxford where he earned three distinguished degrees: an MA in biochemistry, a D.Phil. in pharmacology, and a D.Sc. in physiological sciences, establishing the foundation for his exceptional career. Pertwee embarked on his cannabinoid research journey in 1968 as a post-doctoral researcher, initiating what would become a lifelong dedication to unraveling the complex pharmacology of cannabis compounds. His enduring commitment to this field has positioned him as one of the world's foremost authorities on cannabinoid science.
Professor Pertwee's seminal contributions to cannabinoid pharmacology have revolutionized our understanding of how plant cannabinoids interact with the human body at the molecular level. His extensive research program has systematically explored the therapeutic potential of plant cannabinoids, investigating their pharmacological properties and mechanisms of action with exceptional rigor. Pertwee has made significant advances in understanding allosteric sites on cannabinoid receptors, developed novel CB1 and CB2 receptor ligands, and identified new pharmacological targets for cannabinoids across multiple physiological systems. His work has been instrumental in elucidating the roles of the endocannabinoid system in both health and disease states, providing critical insights that have informed therapeutic development for conditions ranging from chronic pain to neurological disorders. This comprehensive body of research has established the scientific foundation for numerous clinical applications of cannabinoid-based medicines.
Beyond his laboratory achievements, Professor Pertwee has been a transformative leader in building the global scientific community dedicated to cannabinoid research. As co-founder of the International Cannabinoid Research Society, he has played a pivotal role in fostering international collaboration and establishing rigorous scientific standards for cannabinoid studies. His leadership extends to serving as co-chair of the IUPHAR Subcommittee on Cannabinoid Receptors, coordinator of the British Pharmacological Society's Special Interest Group on Cannabinoids, and scientific advisor to the Beckley Foundation, where he has twice presided over the ICRS and chaired the International Association for Cannabinoid Medicines. Currently maintaining active research collaborations and industry partnerships including with GW Pharmaceuticals, Professor Pertwee continues to guide the field toward new discoveries. His ongoing work promises to further illuminate the therapeutic potential of cannabinoids and expand our understanding of this complex biological system.
